Gynecomastia Treatment Market Size was valued at USD 0.81 Billion in 2022. The Gynecomastia Treatment market industry is projected to grow from USD 0.88 Billion in 2023 to USD 1.60 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.80% during the forecast period (2023 - 2032). Growing demand for minimally invasive procedures and increasing awareness and education about gynecomastia are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The growing demand for minimally invasive procedures is a significant driver of the Gynecomastia Treatment market. Patients increasingly prefer minimally invasive approaches, such as liposuction and glandular tissue excision, for gynecomastia correction due to their shorter recovery times, reduced scarring, and overall convenience. Advancements in technologies supporting minimally invasive procedures, including laser and ultrasound-assisted liposuction, contribute to the market's growth. This trend aligns with the broader shift in aesthetic medicine towards less invasive options, meeting patient expectations for effective yet discreet treatments. As awareness of these options expands and technology continues to evolve, the demand for minimally invasive gynecomastia treatments is likely to persist and drive further innovation in the market.
Increasing awareness and education about gynecomastia are pivotal in driving the Gynecomastia Treatment market. As societal understanding of this condition grows, more individuals become aware of available treatment options, leading to an upsurge in patient consultations. Educational efforts by healthcare professionals and awareness campaigns contribute to destigmatizing gynecomastia, encouraging affected individuals to seek medical intervention. The dissemination of information about the causes, impact, and treatment possibilities fosters a proactive approach to addressing this condition. With a more informed public, the demand for gynecomastia treatment rises, driving the market's growth. This trend underscores the importance of ongoing educational initiatives in shaping perceptions and increasing access to appropriate medical care for individuals with gynecomastia.
The rise in male aesthetic concerns is a significant driver of the Gynecomastia Treatment market. With changing societal norms and an increasing emphasis on physical appearance, men are more conscious of aesthetic concerns, including gynecomastia. This cultural shift has led to a growing number of men seeking medical intervention for gynecomastia, driving the demand for treatment options. The stigma associated with male cosmetic procedures has diminished, contributing to greater acceptance. As men become more open about addressing aesthetic concerns, the market for gynecomastia treatment expands. Healthcare providers are responding with tailored solutions, ranging from minimally invasive procedures to surgical interventions, to meet the evolving aesthetic demands of male patients.
For instance, In April 2021, a range of novel technologies emerged for addressing gynecomastia, such as fat grafting and ultrasound-assisted liposuction (UAL). These advancements in technology have widened the scope of tissue removal capabilities through liposuction. Thus, driving the Gynecomastia Treatment market revenue.
The Gynecomastia Treatment Market segmentation, based on type includes Drugs and Surgical Treatment. The drugs segment dominated the market, accounting for 61% of market revenue (0.53 Billion). Drugs have captured the largest market share in the Gynecomastia Treatment market due to their non-invasive nature and efficacy in addressing hormonal imbalances, a common cause of gynecomastia. Medications, such as selective estrogen receptor modulators (SERMs) and aromatase inhibitors, are prescribed to regulate hormone levels and reduce breast tissue enlargement. This drug-based approach is often preferred for mild to moderate cases, offering a less invasive alternative to surgical procedures. As awareness of medical treatments increases, the demand for drug-based interventions remains high, contributing to their dominance in the Gynecomastia Treatment market.
Surgical treatment types are experiencing the highest Compound Annual Growth Rate (CAGR) in the Gynecomastia Treatment market due to their effectiveness in addressing moderate to severe cases. Surgical interventions, including liposuction and glandular tissue excision, provide immediate and visible results. The growing acceptance of aesthetic procedures, coupled with advancements in surgical techniques, has led to an increasing number of individuals opting for surgical treatments. As the demand for long-lasting and transformative solutions rises, surgical treatments continue to grow at a notable CAGR, reflecting a preference for more definitive and comprehensive gynecomastia correction.
The Gynecomastia Treatment Market segmentation, based on application, includes Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. The Hospital Pharmacies category generated the most income (35%). Hospital pharmacies have captured the largest market share in the Gynecomastia Treatment market due to their role as integral components of healthcare institutions. Hospitals serve as primary centers for medical consultations and treatments, including gynecomastia management. The convenience of obtaining prescribed medications directly from hospital pharmacies contributes to their dominance. Additionally, hospitals often provide comprehensive treatment options, including both pharmaceutical and surgical interventions. This centralized approach and the trust associated with hospital-based care result in hospital pharmacies holding the largest market share in the Gynecomastia Treatment landscape.
Online pharmacies are experiencing the highest Compound Annual Growth Rate (CAGR) in the Gynecomastia Treatment market due to the increasing adoption of digital healthcare platforms. The convenience of accessing medications online, coupled with the growing trend of telemedicine consultations, has fueled the demand for pharmaceutical solutions in the virtual space. Online pharmacies provide discreet and efficient services, attracting individuals seeking privacy and convenience for gynecomastia treatment options. The evolving landscape of digital health and the ease of online transactions contribute to the notable growth in the market share of online pharmacies for gynecomastia treatment.
Figure 1: Gynecomastia Treatment Market, by Application, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America has captured the largest market share in the Gynecomastia Treatment market due to factors such as advanced healthcare infrastructure, high awareness levels, and a growing acceptance of aesthetic procedures. The region's robust healthcare system, coupled with a significant emphasis on physical appearance and wellness, drives the demand for gynecomastia treatments. Additionally, the presence of key market players, well-established medical facilities, and the cultural openness to cosmetic interventions contribute to North America's dominance in the Gynecomastia Treatment market.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: Gynecomastia Treatment Market Share By Region 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe has secured the second-largest market share in the Gynecomastia Treatment market owing to its advanced healthcare systems, cultural acceptance of cosmetic procedures, and a proactive approach to men's health. The region's well-established medical infrastructure and increasing awareness of gynecomastia treatment options contribute to market growth. Additionally, regulatory support and a higher prevalence of aesthetic concerns among men further solidify Europe's position as a key player in the Gynecomastia Treatment market, capturing the second-largest market share. Further, the German Gynecomastia Treatment market held the largest market share, and the UK Gynecomastia Treatment market was the fastest growing market in the European region
The Asia Pacific region is experiencing the highest Compound Annual Growth Rate (CAGR) in the Gynecomastia Treatment market due to a rising awareness of aesthetic procedures, evolving healthcare infrastructure, and a growing middle-class population. Increased disposable incomes and changing beauty standards contribute to the demand for gynecomastia treatments. Moreover, the adoption of Western beauty ideals and a surge in medical tourism further drive market growth in the Asia Pacific region. These factors collectively position the region at the forefront of the Gynecomastia Treatment market with the highest CAGR. Moreover, China’s Gynecomastia Treatment market held the largest market share, and the Indian Gynecomastia Treatment market was the fastest growing market in the Asia-Pacific region.
Leading players in the Gynecomastia Treatment market, including pharmaceutical companies, aesthetic clinics, and surgical solution providers, are focusing on expanding their product and service portfolios. They invest in research and development to introduce innovative treatment options and surgical techniques. Additionally, strategic partnerships, mergers, and acquisitions are common strategies to strengthen market developments. These players aim to address the evolving needs of patients seeking gynecomastia treatment by offering a comprehensive range of solutions, contributing to their competitiveness in the dynamic Gynecomastia Treatment industry landscape.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Gynecomastia Treatment industry to benefit clients and increase the market sector. In recent years, the Gynecomastia Treatment industry has offered some of the most significant advantages to medicine. Major players in the Gynecomastia Treatment market, including General Mills Inc., Amway, Conagra Brands Inc., Cargill Incorporated, Abbott Laboratories, Kraft Foods Group Inc., and others, are attempting to increase market demand by investing in research and development operations.
Robert Atkins formed Atkins Nutritionals, Inc. to promote the Atkins diet's low-carbohydrate packaged meals. It is now a subsidiary of The Simply Good Foods Company. Low-carbohydrate bars, shakes, and snacks are available from the company. Atkins Nutritionals, Inc. was formed in 1989 as Complementary Formulations. In 1998, the company was renamed Atkins Nutritionals. It was created to enhance the Atkins diet. Atkins created the plan after reading a research paper in the Journal of the American Medical Association. Alfred W. Pennington published the paper, "Weight Reduction," in 1958. Atkins used the study's findings to help him overcome his own obesity. In May 2019, A partnership agreement between Atkins and CHEF'D was signed. Our collaboration sought to create a low-carb meal solution for consumers concerned about their health and lifestyle.
Brunswick Corporation, formerly known as the Brunswick-Balke-Collender Company, is an American firm founded in 1845 that has been inventing, manufacturing, and distributing a wide range of products. Brunswick now employs over 13,000 people in 24 countries. Among the various boating brands owned by Brunswick are Sea Ray, Boston Whaler, Bayliner, Mercury Marine, Attwood, Lund, Crestliner, Mastervolt, MotorGuide, Harris Pontoons, Freedom Boat Club, Princecraft, Heyday, Lowe, Uttern, Quicksilver, and CZone. In June 2019, A partnership agreement was inked between BRUNSWICK Company and VIR zoom to launch a product called VIR zoom solution. This collaboration, if correctly executed, was expected to transform Life Fitness' se3 explore bikes into a virtual reality experience.
June 2022: Cynosure has unveiled the PicoSure Pro device, representing its most recent enhancement to the PicoSure platform.
March 2022: Sientra's breast implants have obtained regulatory approval from Health Canada. The marketing of breast implants in Canada will be carried out in collaboration with the local partner Kai Aesthetic. Under the distribution agreement, Sientra is committed to maintaining the highest standards of product quality, safety, and service for both patients and plastic surgeons.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 0.81 Billion |
| Market Size 2023 | USD 0.88 Billion |
| Market Size 2032 | USD 1.60 Billion |
| Compound Annual Growth Rate (CAGR) | 7.80% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Allergan plc, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Eli Lilly and Company, AbbVie Inc., Ipsen Pharma, Endo Pharmaceuticals Inc. and Sandoz International GmbH |
| Key Market Opportunities | Rise in male aesthetic concerns is an opportunity for the market |
| Key Market Dynamics | Increasing awareness and education about gynecomastia |
Frequently Asked Questions (FAQ) :
The Gynecomastia Treatment Market size was valued at USD 0.81Billion in 2022.
The global market is projected to grow at a CAGR of 7.80% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Allergan plc, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Eli Lilly and Company, AbbVie Inc., Ipsen Pharma, Endo Pharmaceuticals Inc. and Sandoz International GmbH Company.
The drugs category dominated the market in 2022.
The Hospital pharmacies had the largest share in the global market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
